Detailed information for compound 1087127

Basic information

Technical information
  • TDR Targets ID: 1087127
  • Name: 1-(2,4-dichlorophenoxy)-3-[3-(2-diethylaminoe thyl)-2-iminobenzimidazol-1-yl]propan-2-ol hy drochloride
  • MW: 487.85 | Formula: C22H29Cl3N4O2
  • H donors: 1 H acceptors: 1 LogP: 4.89 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(CCn1c(=N)n(c2c1cccc2)CC(COc1ccc(cc1Cl)Cl)O)CC.Cl
  • InChi: 1S/C22H28Cl2N4O2.ClH/c1-3-26(4-2)11-12-27-19-7-5-6-8-20(19)28(22(27)25)14-17(29)15-30-21-10-9-16(23)13-18(21)24;/h5-10,13,17,25,29H,3-4,11-12,14-15H2,1-2H3;1H
  • InChiKey: RKMYEANRUZMZTD-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-(2,4-dichlorophenoxy)-3-[3-(2-diethylaminoethyl)-2-imino-benzimidazol-1-yl]propan-2-ol hydrochloride
  • 1-(2,4-dichlorophenoxy)-3-[3-(2-diethylaminoethyl)-2-imino-1-benzimidazolyl]propan-2-ol hydrochloride

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.00769783 0.5 0.5
Trypanosoma brucei monoglyceride lipase, putative 0.00769783 0.5 0.5
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.00769783 0.5 0.5
Trypanosoma cruzi monoglyceride lipase, putative 0.00769783 0.5 0.5
Plasmodium falciparum esterase, putative 0.00769783 0.5 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.00769783 0.5 0.5
Trypanosoma brucei monoglyceride lipase, putative 0.00769783 0.5 0.5
Plasmodium falciparum lysophospholipase, putative 0.00769783 0.5 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.00769783 0.5 0.5
Mycobacterium tuberculosis Possible lysophospholipase 0.00769783 0.5 0.5
Plasmodium falciparum lysophospholipase, putative 0.00769783 0.5 0.5
Trichomonas vaginalis valacyclovir hydrolase, putative 0.00769783 0.5 0.5
Plasmodium falciparum lysophospholipase, putative 0.00769783 0.5 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.00769783 0.5 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.00769783 0.5 0.5
Mycobacterium leprae POSSIBLE LYSOPHOSPHOLIPASE 0.00769783 0.5 0.5
Mycobacterium ulcerans lysophospholipase 0.00769783 0.5 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.00769783 0.5 0.5
Plasmodium vivax PST-A protein 0.00769783 0.5 0.5
Trichomonas vaginalis conserved hypothetical protein 0.00769783 0.5 0.5
Mycobacterium ulcerans hypothetical protein 0.00769783 0.5 0.5
Leishmania major monoglyceride lipase, putative 0.00769783 0.5 0.5
Trichomonas vaginalis conserved hypothetical protein 0.00769783 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) 0.9537 uM ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye ChEMBL. 20485428
EC50 (functional) 2.8849 uM ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye ChEMBL. 20485428

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23 20485428

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.